Associated Papers
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions.
Zaremba A et al.
Cancers, 2022
Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway.
Sakakibara K et al.
International Journal of Hematology, 2019
Select a paper to view details